Los Angeles Hematology/Oncology Medical Group — Glendale, California

Public research footprint of Los Angeles Hematology/Oncology Medical Group, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Metastatic Non-Squamous Non-Small Cell Lung Cancer · Breast Neoplasms · Head and Neck Squamous Cell Carcinoma

Recently updated registry entries

NCT05253651 — A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in… (Recruiting)
NCT04152499 — Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to… (Active Not Recruiting)
NCT07062965 — A Study to Learn About the Study Medicine Called PF-07248144 in Combination With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Los Angeles Hematology/Oncology Medical Group?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.